TWO SIGMA INVESTMENTS, LP

Position in SEER — Seer, Inc.

CIK 1179392 NEW YORK, NY

Position in SEER

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$859,484

+$397,140 QoQ

Shares Held

511,598

+102.5% QoQ

Ownership

0.930%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Mar 31, 2026

TWO SIGMA INVESTMENTS, LP holds $5,513,200,662 across 316 Biotechnology names. SEER ranks #203 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,992,577	$659,283,951
2	REGN	Regeneron Pharmaceuticals, Inc.	812,236	$627,566,023
3	MRNA	Moderna, Inc.	9,086,404	$461,589,323
4	IONS	Ionis Pharmaceuticals Inc	5,857,629	$439,849,361
5	BBIO	BridgeBio Pharma, Inc.	3,120,631	$231,738,058
6	VRTX	Vertex Pharmaceuticals Inc / Ma	378,146	$168,857,314
7	RVMD	Revolution Medicines, Inc.	1,558,807	$151,593,980
8	VKTX	Viking Therapeutics, Inc.	4,432,142	$144,221,900

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$859,484	511,598	+102.5%	Shares	Sole	2026-05-15
2025-12-31	$462,344	252,647	-13.6%	Shares	Sole	2026-02-17
2025-09-30	$634,304	292,306	+1.7%	Shares	Sole	2025-11-14
2025-06-30	$615,085	287,423	-6.0%	Shares	Sole	2025-08-14
2025-03-31	$516,671	305,723	-34.9%	Shares	Sole	2025-05-15
2024-12-31	$1,084,748	469,588	-2.7%	Shares	Sole	2025-02-14
2024-09-30	$950,560	482,518	+18.4%	Shares	Sole	2024-11-14
2024-06-30	$684,677	407,546	-4.4%	Shares	Sole	2024-08-14
2024-03-31	$810,211	426,427	+40.4%	Shares	Sole	2024-05-15
2023-12-31	$589,253	303,739	+1124.8%	Shares	Sole	2024-02-14
2023-06-30	$105,896	24,800	+60.0%	Shares	Sole	2023-08-14
2023-03-31	$59,830	15,500	-34.9%	Shares	Sole	2023-05-15
2021-12-31	$543,379	23,822	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.